Anti-CD38 CAR NK-cells: an off-the shelf therapy for multiple myeloma
Michael O’Dwyer, MD, PhD, National University of Ireland, Galway, Ireland, discusses how anti-CD38 CAR NK-cells could selectively target myeloma cells to minimize off-target toxicity. This video was recorded at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.
Get great new content delivered to your inboxSign up
Warning: Invalid argument supplied for foreach() in /home/vjhemonc/public_html/wp-content/themes/vj/single.php on line 296